4.8 Article

Design of multi-scale protein complexes by hierarchical building block fusion

Journal

NATURE COMMUNICATIONS
Volume 12, Issue 1, Pages -

Publisher

NATURE RESEARCH
DOI: 10.1038/s41467-021-22276-z

Keywords

-

Funding

  1. National Science Foundation (NSF) [1629214]
  2. Open Philanthropy Project Improving Protein Design Fund
  3. National Institute of General Medical Sciences [R01GM120553]
  4. National Institute of Allergy and Infectious Diseases [HHSN272201700059C]
  5. Pew Biomedical Scholars Award
  6. Burroughs Wellcome Fund
  7. University of Washington Arnold and Mabel Beckman cryo-EM center
  8. NIH Molecular Biology Training Grant [T32GM008268]
  9. Washington Research Foundation (WRF) Innovation fellowship
  10. US DOE BES Energy Frontier Research Center CSSAS (The Center for the Science of Synthesis Across Scales) at the University of Washington [DESC0019288]
  11. PHS NRSA from NIGMS [T32GM007270]
  12. Human Frontiers Science Program Long Term Fellowship
  13. DOE Office of Biological and Environmental Research
  14. National Institute of Health project ALS-ENABLE [P30 GM124169]
  15. NIH [P30GM124165, S10OD021527, OD019994, RR029300]
  16. DOE [DE-AC02-06CH11357]
  17. National Institutes of Health (NIH)
  18. Howard Hughes Medical Institute
  19. Office of Basic Energy Sciences
  20. US Department of Energy [DE-AC02-05CH11231]
  21. Simons Foundation [SF349247]
  22. NYSTAR
  23. NIH National Institute of General Medical Sciences [GM103310]
  24. Agouron Institute [F00316]
  25. High-End Instrumentation Grant [S10OD018483]
  26. Office of Science
  27. Direct For Mathematical & Physical Scien
  28. Division Of Chemistry [1629214] Funding Source: National Science Foundation

Ask authors/readers for more resources

The study introduces a stepwise hierarchical approach using helical repeat and helical bundle proteins as building blocks for building complex, multi-component protein assemblies, and provides a detailed structural characterization of the resulting assemblies.
A systematic and robust approach to generating complex protein nanomaterials would have broad utility. We develop a hierarchical approach to designing multi-component protein assemblies from two classes of modular building blocks: designed helical repeat proteins (DHRs) and helical bundle oligomers (HBs). We first rigidly fuse DHRs to HBs to generate a large library of oligomeric building blocks. We then generate assemblies with cyclic, dihedral, and point group symmetries from these building blocks using architecture guided rigid helical fusion with new software named WORMS. X-ray crystallography and cryo-electron microscopy characterization show that the hierarchical design approach can accurately generate a wide range of assemblies, including a 43nm diameter icosahedral nanocage. The computational methods and building block sets described here provide a very general route to de novo designed protein nanomaterials. De novo design of self-assembling protein nanostructures and materials is of significant interest, however design of complex, multi-component assemblies is challenging. Here, the authors present a stepwise hierarchical approach to build such assemblies using helical repeat and helical bundle proteins as building blocks, and provide an in-depth structural characterization of the resulting assemblies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Structural basis for broad coronavirus neutralization

Maximilian M. Sauer, M. Alejandra Tortorici, Young-Jun Park, Alexandra C. Walls, Leah Homad, Oliver J. Acton, John E. Bowen, Chunyan Wang, Xiaoli Xiong, Willem de van der Schueren, Joel Quispe, Benjamin G. Hoffstrom, Berend-Jan Bosch, Andrew T. McGuire, David Veesler

Summary: The study identified a monoclonal antibody, B6, that can cross-react with eight beta-coronavirus spike proteins from three viral lineages, targeting a conserved cryptic epitope for potential broad coronavirus neutralization, marking a potential breakthrough in pan-beta-coronavirus vaccine design.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Article Chemistry, Multidisciplinary

High affinity protein surface binding through co-engineering of nanoparticles and proteins

Moumita Ray, Giorgia Brancolini, David C. Luther, Ziwen Jiang, Roberto Cao-Milan, Alejandro M. Cuadros, Andrew Burden, Vincent Clark, Subinoy Rana, Rubul Mout, Ryan F. Landis, Stefano Corni, Vincent M. Rotello

Summary: Control over supramolecular recognition between proteins and nanoparticles is crucial for therapeutic applications and sensor development. Most current binding approaches use tags, but this study presents a new strategy of co-engineering nanoparticles and proteins for high affinity binding. This strategy maintains high binding affinity even under physiological conditions.

NANOSCALE (2022)

Article Multidisciplinary Sciences

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry

Young-Jun Park, Anna De Marco, Tyler N. Starr, Zhuoming Liu, Dora Pinto, Alexandra C. Walls, Fabrizia Zatta, Samantha K. Zepeda, John Bowen, Kaitlin S. Sprouse, Anshu Joshi, Martina Giurdanella, Barbara Guarino, Julia Noack, Rana Abdelnabi, Shi-Yan Caroline Foo, Florian A. Lempp, Fabio Benigni, Gyorgy Snell, Johan Neyts, Sean Pj Whelan, Herbert W. Virgin, Jesse D. Bloom, Davide Corti, Matteo Samuele Pizzuto, David Veesler

Summary: Understanding broadly neutralizing sarbecovirus antibody responses is crucial for developing countermeasures against SARS-CoV-2 variants and future sarbecoviruses. The human monoclonal antibody S2K146 has been found to broadly neutralize ACE2-binding viruses and shows potential for clinical development. Conserved ACE2-binding residues could be leveraged for developing vaccines that elicit broad immunity.

SCIENCE (2022)

Article Multidisciplinary Sciences

Reconfigurable asymmetric protein assemblies through implicit negative design

Danny D. Sahtoe, Florian Praetorius, Alexis Courbet, Yang Hsia, Basile I. M. Wicky, Natasha Edman, Lauren M. Miller, Bart J. R. Timmerman, Justin Decarreau, Hana M. Morris, Alex Kan, Asim K. Bera, David Baker

Summary: This study demonstrates the successful generation of stable, folded, and soluble designs using implicit negative design, which can undergo subunit exchange to enable reconfiguration of various complexes. The approach provides a general route to designing asymmetric reconfigurable protein systems.

SCIENCE (2022)

Article Biochemistry & Molecular Biology

Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein

M. Alejandra Tortorici, Alexandra C. Walls, Anshu Joshi, Young-Jun Park, Rachel T. Eguia, Marcos C. Miranda, Elizabeth Kepl, Annie Dosey, Terry Stevens-Ayers, Michael J. Boeckh, Amalio Telenti, Antonio Lanzavecchia, Neil P. King, Davide Corti, Jesse D. Bloom, David Veesler

Summary: The isolation of CCoV-HuPn-2018 from a child respiratory swab indicates the presence of a previously underappreciated number of coronaviruses infecting humans. This study determined the structures of the virus's spike glycoprotein and its binding to various receptors, as well as the cross-neutralizing activity of antibodies. These findings provide a foundation for the development of vaccines and treatments against this zoonotic pathogen.
Article Surgery

Women with thoracoabdominal aortic aneurysms have increased frailty and more complex aortic anatomy compared with men

Natasha I. Edman, Sara L. Zettervall, Maianna N. Dematteis, Amir Ghaffarian, Sherene Shalhub, Matthew P. Sweet

Summary: This study assessed the gender-related differences in clinical comorbidities, anatomic suitability, and frailty among an unselected cohort of patients with TAAA5. The study found that women with TAAA5 had higher metrics of frailty and anatomic risk that were not captured by comorbidity-based risk assessments, which could explain the lower intervention rates for women with TAAA5.

JOURNAL OF VASCULAR SURGERY (2022)

Article Multidisciplinary Sciences

Large-scale design and refinement of stable proteins using sequence-only models

Jedediah M. Singer, Scott Novotney, Devin Strickland, Hugh K. Haddox, Nicholas Leiby, Gabriel J. Rocklin, Cameron M. Chow, Anindya Roy, Asim K. Bera, Francis C. Motta, Longxing Cao, Eva-Maria Strauch, Tamuka M. Chidyausiku, Alex Ford, Ethan Ho, Alexander Zaitzeff, Craig O. Mackenzie, Hamed Eramian, Frank DiMaio, Gevorg Grigoryan, Matthew Vaughn, Lance J. Stewart, David Baker, Eric Klavins

Summary: In this study, a high-throughput assay was used to evaluate the stability of a large number of novel proteins, and neural network models were built to predict protein stability and generate new protein sequences. The results showed that, despite limitations, the predictive model can significantly improve protein stability.

PLOS ONE (2022)

Article Multidisciplinary Sciences

Computational design of mechanically coupled axle-rotor protein assemblies

A. Courbet, J. Hansen, Y. Hsia, N. Bethel, Y-J Park, C. Xu, A. Moyer, S. E. Boyken, G. Ueda, U. Nattermann, D. Nagarajan, D-A Silva, W. Sheffler, J. Quispe, A. Nord, N. King, P. Bradley, D. Veesler, J. Kollman, D. Baker

Summary: This study explores the construction of protein machinery by designing axle and rotor components, achieving successful assembly in vitro and in vivo, and demonstrating a new approach to protein structure construction.

SCIENCE (2022)

Article Cell Biology

Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice

Andrew C. Hunt, James Brett Case, Young-Jun Park, Longxing Cao, Kejia Wu, Alexandra C. Walls, Zhuoming Liu, John E. Bowen, Hsien-Wei Yeh, Shally Saini, Louisa Helms, Yan Ting Zhao, Tien-Ying Hsiang, Tyler N. Starr, Inna Goreshnik, Lisa Kozodoy, Lauren Carter, Rashmi Ravichandran, Lydia B. Green, Wadim L. Matochko, Christy A. Thomson, Bastian Vogeli, Antje Kruger, Laura A. VanBlargan, Rita E. Chen, Baoling Ying, Adam L. Bailey, Natasha M. Kafai, Scott E. Boyken, Ajasja Ljubetic, Natasha Edman, George Ueda, Cameron M. Chow, Max Johnson, Amin Addetia, Mary-Jane Navarro, Nuttada Panpradist, Michael Gale, Benjamin S. Freedman, Jesse D. Bloom, Hannele Ruohola-Baker, Sean P. J. Whelan, Lance Stewart, Michael S. Diamond, David Veesler, Michael C. Jewett, David Baker

Summary: Researchers used a cell-free expression workflow to screen and optimize constructs containing computationally designed miniprotein inhibitors of SARS-CoV-2. They found that a homotrimeric version of the ACE2 mimic AHB2 (TRI2-2) achieved the broadest efficacy. The TRI2-2 miniprotein neutralized Omicron, Delta, and other variants with greater potency than clinically used monoclonal antibodies. It also provided prophylactic and therapeutic protection against SARS-CoV-2 in mice when administered intranasally. The designed miniprotein receptor mimics offer a widely applicable antiviral therapeutic strategy with advantages over antibodies and native receptor traps.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Multidisciplinary Sciences

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

Young-Jun Park, Dora Pinto, Alexandra C. Walls, Zhuoming Liu, Anna De Marco, Fabio Benigni, Fabrizia Zatta, Chiara Silacci-Fregni, Jessica Bassi, Kaitlin R. Sprouse, Amin Addetia, John E. Bowen, Cameron Stewart, Martina Giurdanella, Christian Saliba, Barbara Guarino, Michael A. Schmid, Nicholas M. Franko, Jennifer K. Logue, Ha V. Dang, Kevin Hauser, Julia di Iulio, William Rivera, Gretja Schnell, Anushka Rajesh, Jiayi Zhou, Nisar Farhat, Hannah Kaiser, Martin Montiel-Ruiz, Julia Noack, Florian A. Lempp, Javier Janer, Rana Abdelnabi, Piet Maes, Paolo Ferrari, Alessandro Ceschi, Olivier Giannini, Guilherme Dias De Melo, Lauriane Kergoat, Herve Bourhy, Johan Neyts, Leah Soriaga, Lisa A. Purcell, Gyorgy Snell, Sean P. J. Whelan, Antonio Lanzavecchia, Herbert W. Virgin, Luca Piccoli, Helen Y. Chu, Matteo Samuele Pizzuto, Davide Corti, David Veesler

Summary: SARS-CoV-2 Omicron sublineages have spike mutations that allow them to evade antibodies from previous infection or vaccination. Hybrid immunity or booster shots can generate neutralizing antibodies against Omicron variants, and breakthrough infections lead to the production of neutralizing antibodies in the nasal mucosa. Antibodies derived from memory B cells or plasma cells of Omicron breakthrough cases show cross-reactivity with different receptor-binding domains, while primary Omicron infections elicit B cells with narrow specificity. A highly potent pan-variant-neutralizing antibody has been identified as a potential candidate for clinical development.

SCIENCE (2022)

Article Biochemistry & Molecular Biology

De novo design of obligate ABC-type heterotrimeric proteins

Sherry Bermeo, Andrew Favor, Ya-Ting Chang, Andrew Norris, Scott E. Boyken, Yang Hsia, Hugh K. Haddox, Chunfu Xu, T. J. Brunette, Vicki H. Wysocki, Gira Bhabha, Damian C. Ekiert, David Baker

Summary: The de novo design of protein chains that associate to form a heterotrimer is a challenging task in protein design. In this study, we designed helical heterotrimers with buried hydrogen bond networks and large aromatic residues. We obtained ten designs in which all three chains assembled into heterotrimers. Crystal structures and electron microscopy confirmed the successful assembly of these designed structures, which could be used for constructing larger protein nanostructures and modulating cell signaling.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2022)

Article Multidisciplinary Sciences

Neutralization, effector function and immune imprinting of Omicron variants

Amin Addetia, Luca Piccoli, James Brett Case, Young-Jun Park, Martina Beltramello, Barbara Guarino, Ha Dang, Guilherme Dias de Melo, Dora Pinto, Kaitlin Sprouse, Suzanne M. Scheaffer, Jessica Bassi, Chiara Silacci-Fregni, Francesco Muoio, Marco Dini, Lucia Vincenzetti, Rima Acosta, Daisy Johnson, Sambhavi Subramanian, Christian Saliba, Martina Giurdanella, Gloria Lombardo, Giada Leoni, Katja Culap, Carley Mcalister, Anushka Rajesh, Exequiel Dellota, Jiayi Zhou, Nisar Farhat, Dana Bohan, Julia Noack, Alex Chen, Florian A. Lempp, Joel Quispe, Lauriane Kergoat, Florence Larrous, Elisabetta Cameroni, Bradley Whitener, Olivier Giannini, Pietro Cippa, Alessandro Ceschi, Paolo Ferrari, Alessandra Franzetti-Pellanda, Maira Biggiogero, Christian Garzoni, Stephanie Zappi, Luca Bernasconi, Min Jeong Kim, Laura E. Rosen, Gretja Schnell, Nadine Czudnochowski, Fabio Benigni, Nicholas Franko, Jennifer K. Logue, Courtney Yoshiyama, Cameron Stewart, Helen Chu, Herve Bourhy, Michael A. Schmid, Lisa A. Purcell, Gyorgy Snell, Antonio Lanzavecchia, Michael S. Diamond, Davide Corti, David Veesler

Summary: The recently emerged BQ.1.1 and XBB.1.5 variants of SARS-CoV-2 have a higher affinity for the host ACE2 receptor and more efficiently promote fusion with host cell membranes compared to earlier Omicron variants. Although the neutralizing activity is reduced, vaccine-induced human plasma antibodies still cross-react with and trigger effector functions against current Omicron variants, providing a mechanism of protection against disease.

NATURE (2023)

No Data Available